Showing results (101-110 of 133) with videos related to
Sort By:
Pageof 14
British Journal of Cancer|May 23, 2013
Proto-oncogenic isoform A2 of eukaryotic translation elongation factor eEF1 is a target of miR-663 and miR-744A Vislovukh, G Kratassiouk, E Porto, et al.Journal of Cardiovascular Pharmacology|July 13, 2000
Echo-dipyridamole stress test evaluation of isosorbide-5-mononitrate efficacy and tolerance in patients with coronary heart disease: interplay with sympathetic activityG Longobardi, N Ferrara, D Leosco, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: a phase II studyA A Brandes, M Ermani, U Basso, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 1, 1997
Effects of lithium and carbamazepine on thyroid hormone metabolism in rat brainA Baumgartner, G Pinna, L Hiedra, et al.Cancer|January 5, 2000
Chemotherapy in patients with recurrent and progressive central neurocytomaA A Brandes, P Amistà, M Gardiman, et al.Brain Research. Molecular Brain Research|December 24, 1997
Dopamine receptor gene expression in an animal model of 'behavioral dependence' on ethanolM Eravci, T Grosspietsch, G Pinna, et al.Anticancer Research|July 1, 1991
Comparative effects of L-methionine, S-adenosyl-L-methionine and 5'-methylthioadenosine on the growth of preneoplastic lesions and DNA methylation in rat liver during the early stages of hepatocarcinogenesisR M Pascale, M M Simile, G Satta, et al.Italian Journal of Pediatrics|September 24, 2016
The transition from intra to extra-uterine life in late preterm infant: a single-center studyM P De Carolis, G Pinna, C Cocca, et al.The Journal of Clinical Endocrinology and Metabolism|September 24, 1998
3,3'-Diiodothyronine concentrations in the sera of patients with nonthyroidal illnesses and brain tumors and of healthy subjects during acute stressG Pinna, L Hiedra, H Meinhold, et al.ESMO Open|October 10, 2024
Leptin as a surrogate immune-metabolic marker to predict impact of anti-cachectic therapy: results of a prospective randomized trial in multiple solid tumorsC Madeddu, G Gramignano, E Lai, et al.Pageof 14